Allen Barnett, PhD

Co-founder, President Emeritus

Dr. Barnett is a successful drug development executive who brought four drugs, two of which are blockbusters, to the marketplace during his tenure at Schering-Plough (SP). He led the effort that resulted in the discovery of Claritin (and Clarinex), a non-sedating antihistamine that is Schering-Plough’s leading product and was the fifth leading drug, based on…

Kejian Zhang, MD, Ph.D

Dr. Kejian Zhang, Professor of School of Pharmaceutical Sciences of Sun Yat-sen University, Chief Scientist of South China Center for Innovative Pharmaceuticals, has over 30 years of experience in pharmaceutical R&D and administration of drug registration in China. He graduated from China Medical University(Shenyang, China), and received a PhD from School of Pharmaceutical Sciences of…

Lewis Ho

Lewis Ho is recognized as one of the leading IP and transactional attorneys in Asia focusing in the life sciences sector. He helps pharmaceutical and biotechnology companies and their financial sponsors to capture, manage, risk assess, evaluate and monetize their intellectual property assets. Lewis has extensive experience advising on both inbound and outbound transactions, and…

Grant Williams, MD

Dr. Williams is President of Williams Cancer Drug Consulting and he is a board certified medical oncologist with 16 years of oncology review experience at FDA and 3 years of experience in oncology clinical development in the pharmaceutical industry. As a consultant, he provides a unique blend of experience in oncology clinical trial design and…

Wen Wee Ma, MBBS

Dr. Ma is an Associate Professor of Oncology in the Department of Medicine at Roswell Park Cancer Institute. Dr. Ma’s areas of expertise include colon cancer, liver cancer, pancreatic cancer and rectal cancer; and his special interests include drug development and Phase I clinical trials (advanced solid tumors). Dr. Ma received his MBBS from the…

Cheung-Tak Hung, PhD, MRPharmS

Dr. C. Tak Hung is the Managing Director and owner of Zenith Technology Corporation Ltd. in Dunedin, New Zealand. He received his degrees in Aberdeen, Scotland. Before establishing Zenith Technology in 1987, he was a senior lecturer in the Pharmacy Department, University of Otago from 1983 to 1987. He has published over 80 research articles…

Leslie Z. Benet, PhD

Dr. Benet, Professor and former Chairman (1978-1998), Department of Bioengineering and Therapeutic Sciences, Schools of Pharmacy and Medicine, University of California, San Francisco, received his AB (English), BS (Pharmacy), MS from the University of Michigan and PhD from the University of California. He has received eight honorary doctorates: Uppsala University, Sweden (PharmD, 1987), Leiden University,…

Daniel Von Hoff, MD, FACP

Dr. Von Hoff is a highly regarded medical oncologist and drug developer, serving in the role of Physician-in-Chief and Distinguished Professor at the Translational Genomics Research Institute (TGen), Professor of Medicine at the Mayo Clinic, Chief Scientific Officer of the HonorHealth Research Institute, and Medical Director of Research as well as Chief Scientific Officer at…

Mr. Collin Lau is the founder of BEI Capital, an Asian-based global real estate and alternative investment company. Collin was previously a managing director, head of global real estate and head of European private equity at China Investment Corporation. With 29 years of corporate, financial and investment management experience, Collin was previously a managing director…

Dr. Hsia is a co-founder of Watson Pharmaceuticals, a publicly traded company listed in New York Stock Exchange (ticker: WPI). He was formerly Senior Vice President of Scientific Affairs of Watson Pharmaceuticals before his retirement. Dr. Hsia was formerly on the Athenex board before he retired in 2011. A veteran of the pharmaceutical industry, Dr. Hsia…